Health economic modelling of diabetic kidney disease in patients with type 2 diabetes treated with Canagliflozin in Belgium
Health economic modelling of diabetic kidney disease in patients with type 2 diabetes treated with Canagliflozin in Belgium is a paper indexed in ScholarIQ from OpenAlex.
How many citations does Health economic modelling of diabetic kidney disease in patients with type 2 diabetes treated with Canagliflozin in Belgium have?
Health economic modelling of diabetic kidney disease in patients with type 2 diabetes treated with Canagliflozin in Belgium has 8 citations in the OpenAlex counts ScholarIQ stores.
When was Health economic modelling of diabetic kidney disease in patients with type 2 diabetes treated with Canagliflozin in Belgium published?
Health economic modelling of diabetic kidney disease in patients with type 2 diabetes treated with Canagliflozin in Belgium has 2021 year in the ScholarIQ index.
What is the open-access status of Health economic modelling of diabetic kidney disease in patients with type 2 diabetes treated with Canagliflozin in Belgium?
Health economic modelling of diabetic kidney disease in patients with type 2 diabetes treated with Canagliflozin in Belgium has closed oa status in the ScholarIQ index.
What is the DOI of Health economic modelling of diabetic kidney disease in patients with type 2 diabetes treated with Canagliflozin in Belgium?
The DOI for Health economic modelling of diabetic kidney disease in patients with type 2 diabetes treated with Canagliflozin in Belgium is on the source record.
What is the PMID of Health economic modelling of diabetic kidney disease in patients with type 2 diabetes treated with Canagliflozin in Belgium?
The PMID for Health economic modelling of diabetic kidney disease in patients with type 2 diabetes treated with Canagliflozin in Belgium is on the source record.
What is the OpenAlex record for Health economic modelling of diabetic kidney disease in patients with type 2 diabetes treated with Canagliflozin in Belgium?
The OpenAlex for Health economic modelling of diabetic kidney disease in patients with type 2 diabetes treated with Canagliflozin in Belgium is on the source record.